市場データを読み込み中...
2026年9月6日日曜日
ホームへ戻るKorea StockKorea Aerospace Industriesの記事をすべて見る

KAI (047810.KS) Q1 2026: Revenue Surges 56% to Record ₩1.09T

執筆 MinJeKim4 回閲覧

この記事の日本語訳は準備中です。以下は英語の原文です。

KAI (047810.KS) Q1 2026: Revenue Surges 56% to Record ₩1.09T

KAI (047810.KS) Q1 2026: Revenue Surges 56% to Record ₩1.09T

FA-50 exports and KF-21 initial production drove a historic quarterly revenue peak, while front-loaded program economics compressed gross margin by 469 basis points and flipped operating cash flow to a ₩77.0 billion deficit.

Source: Q1 2026 Quarterly Report (28th Fiscal Year) — Filed May 15, 2026 with DART | Consolidated Financial Statements | Unit: ₩ billions


Korea Aerospace Industries (KAI) posted consolidated revenue of ₩1,092.7 billion in Q1 2026, a 56.3% year-on-year surge that marks the highest first-quarter result in company history. The performance was driven primarily by accelerating Poland FA-50 export deliveries and the initial production phase of the KF-21 Boramae fighter program, with T-50/KF-21-series aircraft alone contributing ₩447.1 billion — 41.5% of total consolidated revenue. Operating profit rose 43.4% to ₩67.1 billion, yet gross margin fell a more significant 469 basis points to 12.52% as early-stage production economics on KF-21 and the LAH (Marineon) rotorcraft suppressed unit profitability. Simultaneously, the company's balance sheet absorbed a structural shift: a five-year zero-coupon convertible bond issued on March 4 pushed total bonds payable from ₩1,266.4 billion to ₩2,158.7 billion, lifting the debt-to-equity ratio from 446.6% to 473.9%.


Balance Sheet

Asset Profile

ItemEnd-FY2025 (₩bn)Q1 2026 (₩bn)Change
Cash and cash equivalents60.9162.5+166.7%
Trade and other receivables (current + non-current)726.7700.5−3.6%
Inventories3,637.03,811.6+4.8%
Property, plant & equipment993.81,003.1+0.9%
Intangible assets943.7953.6+1.1%

The most significant new entry on the asset side is a ₩500.4 billion balance in fair-value-through-profit-or-loss (FVTPL) financial instruments, representing convertible bond proceeds parked in short-term investment vehicles. Inclusive of this position, KAI's effective near-cash reserves stand at approximately ₩662.9 billion — a materially more comfortable liquidity buffer than the headline cash figure suggests.

Inventories at ₩3,811.6 billion represent 34.1% of total assets, a structural feature of defense-sector percentage-of-completion accounting where unbilled construction costs and undelivered aircraft dominate the balance. The ₩174.6 billion sequential increase reflects advance procurement for KF-21 production units and export aircraft deliveries scheduled across the remainder of the year. Within PPE, assets under construction grew ₩88.0 billion, indicating that capital investment in production capacity is accelerating.

Debt Structure: Financial vs. Operating Liabilities

Financial liabilities — borrowings plus bonds payable — expanded from ₩2,147.0 billion to ₩2,770.0 billion (+29.0%) over the quarter.

Short-term borrowings fell ₩270.0 billion to ₩222.8 billion as the new convertible bond proceeds were deployed to retire floating-rate short-term debt. Bonds payable surged ₩892.3 billion (+70.5%) to ₩2,158.7 billion, entirely attributable to the five-year zero-coupon instrument. Derivative financial liabilities of ₩36.7 billion appeared for the first time, reflecting the early redemption option embedded in the Genoco convertible bond acquired as part of the subsidiary consolidation.

The liability maturity transformation — retiring short-term floating-rate debt and replacing it with a long-dated zero-coupon instrument — is favorable from an interest-cost standpoint and removes near-term refinancing pressure. The trade-off is a puttable feature allowing bondholders to demand early redemption on a quarterly basis beginning March 2029, which creates a potential ₩892.3 billion liquidity event ahead of the 2031 maturity, and ultimate dilution risk if bonds convert at the ₩185,165 strike.

On the operating liability side, trade payables declined modestly from ₩608.6 billion to ₩585.5 billion. More meaningfully, current contract liabilities contracted 10.5% from ₩2,140.5 billion to ₩1,914.9 billion — a positive indicator that advance payments received under export contracts are being drawn down as revenue is recognized on delivered aircraft. The shrinkage in contract liabilities is, in effect, a confirmation of the revenue recognition narrative underpinning the topline surge.

Capital Quality

ItemQ1 2026 (₩bn)Share
Share capital487.325.1%
Share premium124.06.4%
Paid-in capital subtotal611.331.5%
Retained earnings1,228.663.3%
Other equity items23.71.2%
Non-controlling interests81.14.2%

Retained earnings are approximately twice paid-in capital, indicating strong internally generated equity and a history of profitable operations. The ₩6.7 billion sequential decline in retained earnings — despite ₩42.0 billion in net income attributable to the parent — reflects the ₩48.7 billion FY2025 dividend payment processed during the quarter. The dividend payout is a signal of capital discipline rather than distress: management is returning earnings while simultaneously accessing zero-cost long-term debt to fund expansion, a rational capital structure choice given the growth backlog.


Income Statement

Core Metrics (Q1 2025 vs. Q1 2026)

MetricQ1 2025 (₩bn)Q1 2026 (₩bn)Change
Revenue699.21,092.7+56.3%
Gross profit120.3136.7+13.7%
Gross margin17.21%12.52%−469 bps
Operating profit46.867.1+43.4%
Operating margin6.69%6.14%−55 bps
Net income29.141.3+41.6%
Net margin4.17%3.78%−39 bps

Revenue Composition and Mix Shift

The 56.3% topline surge reflects a structural shift in product mix toward export programs. On a standalone basis, exports to Poland and other foreign clients accounted for 28.49% of revenue in Q1 2026, up from 25.53% in full-year FY2025 and 17.79% in FY2024 — a consistent multi-year trajectory. T-50/KF-21-series aircraft contributed ₩447.1 billion, equivalent to 41.5% of total consolidated revenue, confirming that the fighter and trainer-fighter franchise is the primary engine of near-term growth. Boeing and Airbus aerostructure subcontracts represented 8.25% and 9.51% of standalone revenue respectively, providing a diversified commercial floor beneath the lumpier defense-export cycle.

Gross Margin Compression

The 469-basis-point collapse in gross margin to 12.52% is the quarter's most important quality signal. Cost of revenue reached ₩956.0 billion at an 87.5% cost ratio. Two structural factors are simultaneously at work: the KF-21 program is in its initial production phase, where learning-curve economics have not yet materialized and percentage-of-completion accounting tends to record lower early-stage margins as cost estimates for initial units are conservative; and the LAH (Marineon) light armed helicopter carries an identical front-loaded cost burden in its own production ramp. Both are characteristics of complex defense programs that improve as cumulative production volume builds — but the timing and magnitude of that recovery depend on production cadence decisions that remain at the discretion of the Defense Acquisition Program Administration.

Fixed-Cost Leverage and Operating Efficiency

Selling, general & administrative expenses held at ₩69.6 billion, representing just 6.37% of revenue — demonstrating meaningful operating leverage on the fixed overhead base as volume scales. Raw material outlays for the quarter totaled ₩648.6 billion (LRU functional components ₩386.4 billion; raw materials ₩100.2 billion; hardware ₩59.3 billion), equal to 67.9% of cost of revenue. This variable-heavy cost structure means that margin expansion on incremental revenue is primarily a function of learning-curve progress on KF-21 and LAH rather than fixed-cost absorption.

Research and development expenditure on a standalone basis was ₩31.8 billion (2.95% of standalone revenue), modestly below FY2025's full-year intensity of 4.52%, though the underlying research workforce of 2,253 engineers — including 1,024 with master's or doctoral degrees — remains intact. The operating leverage arithmetic is instructive: the 56% revenue surge converted into a 43% operating profit gain, and any further double-digit volume expansion would push the operating margin back toward double digits, provided gross margin stabilizes at current levels.


Cash Flow

ItemQ1 2025 (₩bn)Q1 2026 (₩bn)Change
Operating cash flow+161.1−77.0−238.1
Investing cash flow−316.3−544.5−228.2
Financing cash flow+177.1+722.5+545.4
Closing cash balance162.5

Operating Cash Flow Swing to Deficit

The ₩77.0 billion operating deficit represents the quarter's sharpest divergence from accounting profit. Net income of ₩41.3 billion plus non-cash charges of ₩62.9 billion were more than erased by a ₩147.7 billion working capital drag. This is a direct and predictable consequence of the revenue surge: under percentage-of-completion accounting, recognized income outruns the pace at which contract milestones trigger actual cash receipts, widening the gap between reported profit and realized liquidity. Interest payments tripled from ₩7.0 billion to ₩20.6 billion, reflecting the expanded borrowing base and foreshadowing further interest cost growth in subsequent quarters as the full-period impact of the new convertible bond runs through the income statement.

Investing Activities

The ₩544.5 billion cash outflow from investing was dominated by ₩499.6 billion in FVTPL financial instrument acquisitions — the convertible bond proceeds being deployed into short-term instruments rather than left idle. Underlying capital expenditure (PPE additions of ₩30.0 billion plus intangible additions of ₩11.1 billion) totaled ₩41.1 billion, a conservative level that reflects the asset-light nature of much of KAI's manufacturing, where customer-funded tooling and government-provided facilities reduce the private capex requirement.

Free Cash Flow

FCF = operating cash flow (−₩77.0 billion) minus capex (₩41.1 billion) = approximately −₩118.1 billion for the quarter. The negative reading is not alarming in isolation given the growth-phase working capital dynamics, but a persistent FCF deficit over two to three consecutive quarters would signal that the financing requirement for the growth program is structurally larger than current earnings can self-fund.


Key Findings

Order Backlog at ₩26.55 Trillion — Rich but Slowly Shrinking

KAI's standalone order backlog opened the year at ₩27.34 trillion and closed Q1 2026 at ₩26.55 trillion, a net reduction of ₩790.5 billion over three months. Domestic defense orders fell 3.4% to ₩10,613.4 billion; aircraft export orders declined 2.8% to ₩5,365.8 billion; every segment contracted. At the current quarterly revenue run rate of approximately ₩1.1 trillion, the backlog covers roughly 24 quarters of production — an extraordinarily deep buffer by any industrial benchmark. But the direction matters: revenue recognition is running ahead of new contract inflows, and whether fresh signings can replenish the backlog at the required pace is the single most important variable to monitor over the next three to six months.

Zero-Coupon Convertible Bond: Capital Efficiency with Embedded Dilution Risk

The five-year zero-coupon convertible issued on March 4 eliminates near-term interest expense on ₩892.3 billion of incremental debt while deferring the cash obligation to 2031. The instrument is clever balance sheet engineering for a company with a long, visible contract backlog — it effectively monetizes future cash flows at zero carry cost. The risks are specific: bondholders may demand early redemption quarterly from March 2029, creating a potential ₩892.3 billion liquidity event ahead of maturity; and full conversion at ₩185,165 per share would dilute existing shareholders at a fixed strike that may sit below prevailing market prices at conversion time, depending on the intervening share price trajectory.

M&A Integration: Genoco, Korea Surface Treatment, and European Subsidiary

Three entities were consolidated over the past two quarters: Genoco (satellite communications, Q3 2025), Korea Surface Treatment (airframe coating and processing, Q4 2025), and a newly established European subsidiary based in Poland (June 2025). The acquisitions deepen vertical integration in targeted ways — Genoco supports domestic X-Band satellite transmitter development, while Korea Surface Treatment internalizes an airframe manufacturing step previously sourced externally. Consolidated Q1 revenue exceeded standalone revenue by approximately ₩15.0 billion, indicating that initial consolidation contributions are meaningful but not yet transformational; that should change as these subsidiaries reach operational maturity.

Debt-to-Equity Ratio of 473.9% — Defense-Sector Context Required

The headline leverage figure is alarming in isolation but misleading without industry context. Contract liabilities of ₩1,914.9 billion — advance payments from foreign and domestic clients for aircraft under production — constitute a significant component of total liabilities. These are operational obligations collateralized by work-in-progress inventory, not financial debt in the traditional sense. Adjusting for this, net debt as a share of total assets stands at 18.88%, actually an improvement from 20.12% at year-end 2025, and a more meaningful gauge of KAI's true financial leverage as a defense prime contractor.


Outlook

KAI enters the remainder of 2026 with the most visible demand environment in its history. The global military aircraft market is expanding under the combined pressure of Eastern European rearmament and Indo-Pacific security competition, and KAI occupies a structurally differentiated position: the KF-21 Boramae is the only independently developed fourth-generation fighter produced outside the traditional Western and Russian defense primes at this scale, while the FA-50 has established a proven export track record across Southeast Asia and Eastern Europe. The ₩26.55 trillion backlog — equivalent to roughly 24 quarters of production — provides exceptional forward revenue visibility, and the rotorcraft portfolio (LAH Marineon, MAH maritime helicopter, MCH minesweeping helicopter) adds meaningful program diversification beyond fixed-wing.

The bull case compounds on several layers: FA-50 export expansion to markets beyond Poland, KF-21 learning-curve margin recovery as cumulative production volume builds, and longer-dated optionality from manned-unmanned teaming (MUM-T) systems and next-generation rotorcraft contracts currently in development. If gross margin recovers toward the 17% level seen in Q1 2025, even modest revenue growth from current levels would push operating margin comfortably into double digits.

The risks are specific and trackable. Gross margin at 12.52% is structurally compressed by the simultaneous early-production ramp of KF-21 and LAH — recovery depends on production cadence acceleration that has not yet been demonstrated in the data. Negative operating cash flow of ₩77.0 billion in Q1 establishes that working capital management will remain a binding constraint through at least mid-year; if the deficit persists, additional borrowing would further stress an already elevated balance sheet. The convertible bond's early redemption window opening in March 2029 introduces a medium-term liquidity cliff that management will need to address well in advance. And the pace of new contract awards must at minimum match the current revenue recognition rate to prevent the backlog from eroding toward levels that call into question the ₩5 trillion annual revenue trajectory.

The overall picture is a company in a genuine growth phase — topline momentum is real, well-supported by backlog, and driven by products with legitimate international competitive standing — but where margin and cash flow quality require two to three more quarters of evidence before the operating leverage argument can be made with confidence.


This report is prepared for informational purposes based on regulatory filings submitted to DART (Data Analysis, Retrieval and Transfer System) and does not constitute investment advice or a solicitation to buy or sell any security. All financial data is sourced from KAI's Q1 2026 quarterly report (28th fiscal year) filed May 15, 2026. Forecasts and interpretations reflect publicly available information only. Past financial performance is not indicative of future results. Investors should conduct independent due diligence before making any investment decision.

見出しの先を読む

何が起きたかは読みました。次は、それが何を意味するかを。

無料デイリーブリーフィング

米国市場を毎朝 — 無料で

LineVest Dailyが寄付き前に届きます:米国市場の主要ストーリー、決算、開示、外国人フロー — わかりやすい英語で。無料、カード登録不要。

LineVest Dailyを無料で →
この企業

KAIの詳細レポート

KAIの最新SEC開示を全て読み込みます — US GAAPの財務、ガバナンス、株価への意味まで。3時間以内にPDFでお届け。

$12・買い切り

KAIレポートを入手
ウォッチ銘柄すべて

市場全体をフォロー

週に何銘柄も米国株を見ていますか?すべての分析記事を公開と同時に — デイリーの米国市場全カバレッジと90日アーカイブ。

$9.99・月額

購読する

一次資料のSEC開示に基づく独立ジャーナリズム — 投資助言ではありません。証券会社との提携はありません。

関連記事

How to Read Korean DART Filings in English: A Guide for Foreign Investors
企業分析

How to Read Korean DART Filings in English: A Guide for Foreign Investors

サムスン電子(005930.KS)2026年Q2:営業利益89.5兆ウォンで過去最高、MXは2011年以来初の四半期赤字
企業分析

サムスン電子(005930.KS)2026年Q2:営業利益89.5兆ウォンで過去最高、MXは2011年以来初の四半期赤字

セルトリオン、2026年Q2決算を修正開示――営業利益4,300億ウォンの過去最高を確認
企業分析

セルトリオン、2026年Q2決算を修正開示――営業利益4,300億ウォンの過去最高を確認

企業分析

ABLバイオ(298380.KQ)2026年第1四半期:損失48%縮小、現金₩1,867億保有

EOテクニクス (039030.KQ) 2026年1Q:HBMレーザー需要急増で営業利益が倍増
企業分析

EOテクニクス (039030.KQ) 2026年1Q:HBMレーザー需要急増で営業利益が倍増

三千堂製薬(000250.KS)FY2025:アイリアバイオシミラー発売が牽引、営業利益220%急増・最終黒字転換
企業分析

三千堂製薬(000250.KS)FY2025:アイリアバイオシミラー発売が牽引、営業利益220%急増・最終黒字転換

OCIホールディングス(010060.KS)2026年Q2:テキサス太陽光が牽引し売上高58%増・3四半期連続黒字
企業分析

OCIホールディングス(010060.KS)2026年Q2:テキサス太陽光が牽引し売上高58%増・3四半期連続黒字

コーロン・ティッシュジーン(950160.KQ)2026年Q1:純損失₩99.9BのうちTG-C第3相主要エンドポイント未達で95%が非現金デリバティブ
企業分析

コーロン・ティッシュジーン(950160.KQ)2026年Q1:純損失₩99.9BのうちTG-C第3相主要エンドポイント未達で95%が非現金デリバティブ

ジュソン・エンジニアリング(036930.KQ)2026年Q1:売上高54.9億ウォンへ半減、R&D費が売上の46%に達し営業損失70億ウォン
企業分析

ジュソン・エンジニアリング(036930.KQ)2026年Q1:売上高54.9億ウォンへ半減、R&D費が売上の46%に達し営業損失70億ウォン

レインボーロボティクス(277810.KQ)2026年第1四半期:サムスン電子の支援で売上高116.6%急増、研究開発費の重さで営業損失が拡大
企業分析

レインボーロボティクス(277810.KQ)2026年第1四半期:サムスン電子の支援で売上高116.6%急増、研究開発費の重さで営業損失が拡大

アルテオジェン(196170.KQ)2026年Q1:販管費120%急増で営業利益36%減、₩8,675億バイオジェン契約を締結
企業分析

アルテオジェン(196170.KQ)2026年Q1:販管費120%急増で営業利益36%減、₩8,675億バイオジェン契約を締結

エコプロ (086520.KQ) 2026年1Q:₩247.3Bの損益転換、粗利益率が2倍に
企業分析

エコプロ (086520.KQ) 2026年1Q:₩247.3Bの損益転換、粗利益率が2倍に